|
|
||||||||
Eur J Cardiothorac Surg 1998;13:599-603
© 1998 Elsevier Science NL
a Department of Surgery, Mayo Clinic and Foundation, Rochester, MN 55905, USA
b Division of Endocrinology and Metabolism, Mayo Clinic and Foundation, Rochester, MN 55905, USA
c Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, MN 55905, USA
Received 29 September 1997; received in revised form 9 February 1998; accepted 24 February 1998.
Corresponding author. Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN 55905, USA. Tel.: +1 507 255 6038; fax: +1 507 255 4500.
Objective: The transfer of recombinant genes to donor organs may allow for novel therapeutic approaches to the challenges of acute and chronic rejection. Adenoviral vectors are capable of efficient gene transfer, but use of these vectors during donor organ preservation may be less efficient due to the low temperature. This study was designed to examine the effect of temperature on the efficiency of adenovirus-mediated gene transfer. Methods: Gene transfer to human endothelial cells, porcine vascular smooth muscle cells and cultured rat thoracic aortas was examined. Incubation with an adenoviral vector encoding for E. coli ß-galactosidase was performed for 1 h at three different temperatures: 4°C, 10°C and 37°C. Transgene expression was assessed by histochemical staining for ß-galactosidase in transduced cells and by evaluation of ß-galactosidase activity in organ cultures. Results: Both in human endothelial cells and vascular smooth muscle cells the percentage of positively staining cells following transduction at 37°C was significantly greater than at 4°C and at 10°C±30.55±7.26% vs. 14.29±3.79% and 12.43±2.47%, respectively for endothelial cells, P<0.01 vs. 4°C and 10°C; and 28.25±4.52% vs. 17.91±3.76% and 16.63±3.92%, respectively for smooth muscle cells, P<0.05 vs. 4°C, P<0.01 vs. 10°C). ß-galactosidase activity was significantly greater in aortas transduced at 37°C than in vessels transduced at 4°C and 10°C (289 700±113 300 vs. 149 600±54 390 and 108 800±23 140 relative chemiluminesce units/mg of total protein, respectively; P<0.05 vs. 4°C, P<0.001 vs. 10°C). Conclusions: The present study demonstrates that the efficiency of adenovirus-mediated gene transfer is significantly reduced at lower temperatures. The need for cold preservation of donor organs may render efficient adenovirus-mediated gene transfer more difficult in the transplantation setting.
Key Words: Adenovirus Gene transfer Gene therapy Endothelial cells Vascular smooth muscle cells Transplantation
This article has been cited by other articles:
![]() |
C. K. Chiu-Pinheiro, T. O'Brien, Z. S. Katusic, L. F. Bonilla, C. E. Hamner, and H. V. Schaff Gene transfer to coronary artery bypass conduits Ann. Thorac. Surg., October 1, 2002; 74(4): 1161 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yap, C. Pellegrini, T. O'Brien, H. D. Tazelaar, and C. G.A. McGregor Conditions of vector delivery improve efficiency of adenoviral-mediated gene transfer to the transplanted heart Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 702 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pellegrini, A. Jeppsson, C. B. Taner, T. O’Brien, V. M. Miller, H. D. Tazelaar, and C. G. A. McGregor HIGHLY EFFICIENT EX VIVO GENE TRANSFER TO THE TRANSPLANTED HEART BY MEANS OF HYPOTHERMIC PERFUSION WITH A LOW DOSE OF ADENOVIRAL VECTOR J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 493 - 500. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |